or Try an Advanced Search...

    Technical Analysis for ATNF - 180 Life Sciences Corp.

    Grade Last Price % Change Price Change
    D 2.50 -6.72% -0.18
    ATNF closed down 6.72 percent on Friday, November 15, 2024, on 3 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Down Down
    Historical ATNF trend table...
    Date Alert Name Type % Chg
    Fell Below 50 DMA Bearish 0.00%
    MACD Bearish Centerline Cross Bearish 0.00%
    200 DMA Support Bullish 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    50 DMA Support Bullish -6.72%
    Narrow Range Bar Range Contraction -6.72%
    Wide Bands Range Expansion -6.72%
    Older End-of-Day Signals for ATNF ...

       Recent Intraday Alerts

    Alert Time
    200 DMA Support 3 days ago
    Down 10% 3 days ago
    Down 5% 3 days ago
    Down 3% 3 days ago
    Up 5% 3 days ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    ATNF Chart by TradingView
    Basic chart:

    Profile

    180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. 180 Life Sciences is leading the research into solving one of the world’s biggest drivers of disease – inflammation. The Company is driving groundbreaking study into clinical programs, which are seeking to develop novel drugs addressing separate areas of inflammation for which there are no effective therapies. The Company’s primary platform is a novel program to treat fibrosis using anti-TNF, with its lead program in phase 2b/3 clinical trials.
    Classification
    Sector: Industrials
    Industry: Conglomerates
    Keywords: Biotechnology Clinical Medicine Disease Immunology Pain Inflammation Inflammatory Diseases Cytokine Fibrosis Human Physiology Tumor Necrosis Factor Animal Physiology

    Is ATNF a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 2 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 31 180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration
    Oct 29 180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors
    Oct 25 Elray Resources Announces Strategic Sale of Crypto iGaming Technology
    Oct 23 Soaring $1-handle stocks leaping into IBKR’s most-active list may point to market froth
    Oct 17 180 Life Sciences' Brave Decision To Switch to the iGaming Industry
    Oct 17 Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
    Oct 16 Dow Jumps 250 Points; U.S. Bancorp Earnings Top Views
    Oct 16 180 Life Sciences Corp. Interim CEO, Blair Jordan, Issues Letter to Stockholders; Provides Update on Newly Acquired Gaming Technology Platform
    Oct 9 180 Life Sciences regains compliance with Nasdaq's minimum stockholders' equity rule
    Oct 9 180 Life Sciences Corp. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Rule and Expands into the Global iGaming Sector
    See more ATNF news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 17.75
    52 Week Low 1.16
    Average Volume 2,507,686
    200-Day Moving Average 2.40
    50-Day Moving Average 2.66
    20-Day Moving Average 3.61
    10-Day Moving Average 2.98
    Average True Range 0.74
    RSI (14) 42.20
    ADX 47.45
    +DI 49.77
    -DI 21.47
    Chandelier Exit (Long, 3 ATRs) 5.78
    Chandelier Exit (Short, 3 ATRs) 4.62
    Upper Bollinger Bands 5.01
    Lower Bollinger Band 2.20
    Percent B (%b) 0.11
    BandWidth 77.77
    MACD Line -0.04
    MACD Signal Line 0.15
    MACD Histogram -0.1957
    Fundamentals Value
    Market Cap 25.4 Million
    Num Shares 10.2 Million
    EPS -14.20
    Price-to-Earnings (P/E) Ratio -0.18
    Price-to-Sales 0.00
    Price-to-Book 0.36
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.15
    Resistance 3 (R3) 3.18 3.01 3.04
    Resistance 2 (R2) 3.01 2.84 2.99 3.00
    Resistance 1 (R1) 2.75 2.74 2.67 2.72 2.97
    Pivot Point 2.58 2.58 2.53 2.56 2.58
    Support 1 (S1) 2.32 2.41 2.24 2.29 2.03
    Support 2 (S2) 2.15 2.31 2.13 2.00
    Support 3 (S3) 1.89 2.15 1.96
    Support 4 (S4) 1.86